Furthermore, as a steroid-metabolizing enzyme, CYP1A1 is part of cancer metabolic processes relevant to steroid hormone responsive tumors, such as breast cancer, ovarian cancer, and prostate cancer [38–41]. The gene discussed is CYP1A1; the disease is prostate cancer.